ELI LILLY AND COMPANY for ELI LILLY AND COMPANY
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Implementation of the Tax Cuts and Jobs Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSE PRICE | — |
| JENNIFER ROMANS | — |
| SONYA SOTAK ELLING | — |
Copyright/Patent/Trademark CPT
Hatch Waxman Integrity Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KYLE New | Legislative Aid, US House of Representatives (2000-2003) Legislative Assistant, US Senate (2007-2011) |
| JESSE PRICE | — |
| JENNIFER ROMANS | — |
| SONYA SOTAK ELLING | — |
Trade (domestic/foreign) TRD
Sanitary and phytosanitary issues (SPS); Japan; Turkey (country) Pricing; IPR and Pricing; Canada IP; USMCA Passage; Saudi Arabia; Thailand OCPA; Malaysia Compulsory Licenses; Special 301
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BURKHEAD New | — |
| HARRISON C COOK | — |
| CATHERINE HINCKLEY | — |
| SARAH KYLE | — |
| JESSE PRICE | — |
| JENNIFER ROMANS | — |
| SONYA SOTAK ELLING | — |
| DAVID TALBOT | — |
Health Issues HCR
Patient protection; Drug shortages; Drug pricing and value; Dormant Therapies Act; PDUFA; BSUFA
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KYLE New | Legislative Aid, US House of Representatives (2000-2003) Legislative Assistant, US Senate (2007-2011) |
| JENNIFER ROMANS | — |
| SONYA SOTAK ELLING | — |
| DAVID TALBOT | — |
Medicare/Medicaid MMM
Intellectual property; Dormant Therapies Act; 340B Program; PPACA
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KYLE New | Legislative Aid, US House of Representatives (2000-2003) Legislative Assistant, US Senate (2007-2011) |
| JESSE PRICE | — |
| JENNIFER ROMANS | — |
| SONYA SOTAK ELLING | — |
Consumer Issues/Safety/Products CSP
Anti-counterfeiting; Patient safety; Drug pedigree; Serialization and traceability issues; Drug Quality and Security Act; Protecting consumers from illegal online drug sales; Promoting public-private partnerships; UN High Level Panel on Access to Medicines (NHHLP) and other multi-lateral threats to IP and the biopharmaceutical industry; Drug importation
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KYLE New | Legislative Aid, US House of Representatives (2000-2003) Legislative Assistant, US Senate (2007-2011) |
| JESSE PRICE | — |
| JENNIFER ROMANS | — |
| SONYA SOTAK ELLING | — |
Pharmacy PHA
Hospital discounts; 340B program
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH KYLE New | Legislative Aid, US House of Representatives (2000-2003) Legislative Assistant, US Senate (2007-2011) |
| SONYA SOTAK ELLING | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.